ConductScience.org, home

Trial · NCT01919697

Results by group28

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE)Plecanatide 3 mg123Participants
Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE)Plecantide 6 mg620Participants
Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE) Leading to Discontinuation of PlecanatidePlecanatide 3 mg14Participants
Number of Patients With at Least One Treatment-Emergent Adverse Event (TEAE) Leading to Discontinuation of PlecanatidePlecantide 6 mg111Participants
Summary of Vital Signs at >Day 364 - Blood Pressure (Systolic and Diastolic; mmHg)Plecanatide 3 mgSystolic Blood Pressure121Standard Deviation 13.40mmHg
Summary of Vital Signs at >Day 364 - Blood Pressure (Systolic and Diastolic; mmHg)Plecantide 6 mgSystolic Blood Pressure122.9Standard Deviation 14.11mmHg
Summary of Vital Signs at >Day 364 - Blood Pressure (Systolic and Diastolic; mmHg)Plecanatide 3 mgDiastolic Blood Pressure75.7Standard Deviation 9.19mmHg
Summary of Vital Signs at >Day 364 - Blood Pressure (Systolic and Diastolic; mmHg)Plecantide 6 mgDiastolic Blood Pressure76.5Standard Deviation 8.47mmHg
Summary of Vital Signs at >Day 364 - Heart Rate (Beats Per Minute)Plecanatide 3 mg71.2Standard Deviation 10.03beats per minute
Summary of Vital Signs at >Day 364 - Heart Rate (Beats Per Minute)Plecantide 6 mg71.9Standard Deviation 9.30beats per minute
Summary of Vital Signs at >Day 364 - Body Temperature (°C)Plecanatide 3 mg36.62Standard Deviation 0.329°C
Summary of Vital Signs at >Day 364 - Body Temperature (°C)Plecantide 6 mg36.59Standard Deviation 0.378°C
Summary of Vital Signs at >Day 364 - Respiration Rate (Breaths Per Minute)Plecanatide 3 mg15.7Standard Deviation 2.03breaths per minute
Summary of Vital Signs at >Day 364 - Respiration Rate (Breaths Per Minute)Plecantide 6 mg16.0Standard Deviation 2.31breaths per minute
Summary of ECG Results Shift From Baseline at > Day 364Plecanatide 3 mgChange from Normal to Abnormal27participants
Summary of ECG Results Shift From Baseline at > Day 364Plecantide 6 mgChange from Normal to Abnormal42participants
Summary of ECG Results Shift From Baseline at > Day 364Plecanatide 3 mgChange from Adnormal to Normal15participants
Summary of ECG Results Shift From Baseline at > Day 364Plecantide 6 mgChange from Adnormal to Normal44participants
Summary of Treatment-Emergent Laboratory Abnormalities With At Least a 1-grade Shift From BaselinePlecanatide 3 mg192participants
Summary of Treatment-Emergent Laboratory Abnormalities With At Least a 1-grade Shift From BaselinePlecantide 6 mg1498participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01919697/results